Effect of lactoferrin for vaginitis and cervicitis in obstetrics

JRCT ID: jRCTs021190020

Registered date:18/02/2020

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Vacterial vaginitis, threatened preterm birth
• Date of first enrollment: 18/02/2020
• Target sample size: 40
• Study type: Interventional
• Intervention(s): Give enteric lactoferrin to pregnant women with abnormal vaginal flora

Outcome(s)

Primary Outcome

1. Intractable vagus or cervical inflammation patients improve vaginal discharge findings by taking lactoferrin-enter-soluble tablets
2. Preterm Birth Rate of Pregnant Women With Lactoferrin Enter-Dissolved Tablets

• Secondary Outcome: Evaluation of side effects and other safety caused by lactoferrin-enter-lytic tablets

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: < 50age old
• Gender: Female

Include criteria

1) Maternal age: 20 years old or older, under 50 years
2) Pregnant women who plan to deliver in our department
3) Patients who have been diagnosed with intractable vaginitis or cervicitis, and who have not improved their vaginal discharge findings with conventional treatment

• Exclude criteria: If not gain consent

Related Information

• Primary Sponsor: Miura Hiroshi
• Source(s) of Monetary Support: Akita University Hospital